Inventor
DOCKAL MICHAEL
AT31 patents
⚠️ This page may combine multiple inventors who share the name “DOCKAL MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAXALTA INC
8 patentsUS10822376B2Nov 3, 2020
Biologically active peptides
BAXALTA INC1 citations73
US9873892B2Jan 23, 2018
Production of fully processed and functional factor X in a furin-secreting mammalian expression system
BAXALTA INC2 citations66
US11160850B2Nov 2, 2021
Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
BAXALTA INC0 citations52
US10287319B2May 14, 2019
Biologically active peptides
BAXALTA INC0 citations52
US9598464B2Mar 21, 2017
Biologically active peptides
BAXALTA INC0 citations52
US10124033B2Nov 13, 2018
Peptides and methods of use
BAXALTA INC0 citations49
US10036002B2Jul 31, 2018
Factor X activation
BAXALTA INC0 citations46
US9545436B2Jan 17, 2017
Methods for treating bleeding disorders using a platelet subpopulation
BAXALTA INC0 citations42
BAXTER INT
8 patentsUS9018167B2Apr 28, 2015
TFPI inhibitors and methods of use
BAXTER INT3 citations73
US9447147B2Sep 20, 2016
Peptides and methods of use
BAXTER INT3 citations70
US8022187B2Sep 20, 2011
FVIII-independent FIX-mutant proteins for hemophilia A treatment
BAXTER INT4 citations63
US9556230B2Jan 31, 2017
TFPI inhibitors and methods of use
BAXTER INT1 citations62
US8962563B2Feb 24, 2015
TFPI inhibitors and methods of use
BAXTER INT3 citations62
US9206234B2Dec 8, 2015
Biologically active peptides
BAXTER INT0 citations52
US9046536B2Jun 2, 2015
Methods and compositions for treating bleeding disorders
BAXTER INT0 citations52
US9417251B2Aug 16, 2016
Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
BAXTER INT0 citations42
DOCKAL MICHAEL
7 patentsUS8450275B2May 28, 2013
TFPI inhibitors and methods of use
DOCKAL MICHAEL13 citations91
US8546096B2Oct 1, 2013
Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
DOCKAL MICHAEL14 citations83
US8466108B2Jun 18, 2013
TFPI inhibitors and methods of use
DOCKAL MICHAEL10 citations83
US8513386B2Aug 20, 2013
FVIII-independent FIX-mutant proteins for hemophilia a treatment
DOCKAL MICHAEL3 citations62
US8632991B2Jan 21, 2014
Methods and compositions for treating bleeding disorders
DOCKAL MICHAEL0 citations51
US8435792B2May 7, 2013
Methods and compositions for treating bleeding disorders
DOCKAL MICHAEL0 citations51
US9566364B2Feb 14, 2017
Preparations based on fibrinogen and sulfated polysaccharides
DOCKAL MICHAEL0 citations49
Baxalta GmbH
5 patentsUS10201586B2Feb 12, 2019
TFPI inhibitors and methods of use
Baxalta GmbH10 citations92
US10800816B2Oct 13, 2020
TFPI inhibitors and methods of use
Baxalta GmbH10 citations83
US11001613B2May 11, 2021
TFPI inhibitors and methods of use
Baxalta GmbH1 citations62
US9777051B2Oct 3, 2017
TFPI inhibitors and methods of use
Baxalta GmbH1 citations62
US9873720B2Jan 23, 2018
TFPI inhibitors and methods of use
Baxalta GmbH1 citations51